JDD in the Media

Are Dermatologists Prepared for Natural and Manmade Disasters?

By January 31, 2020February 14th, 2020No Comments

Natural and manmade disasters cause a range of dermatologic manifestations, including secondary infections after a flood, irritation from blistering agents used in chemical warfare, or acute and chronic effects of cutaneous radiation syndrome.

In a study, “A Survey of Dermatologists’ Preparedness for Natural and Man-made Disasters,” (January 2020 Journal of Drugs in Dermatology), Adam Friedman, MD, interim chair of the Department of Dermatology at the GW School of Medicine and Health Sciences, finds that dermatologists are under prepared for biological disasters, and would benefit from comprehensive preparedness training.
“Recognizing and diagnosing the conditions that can arise following a disaster requires diagnostic acumen, knowledge on reporting, and short- and long-term management strategies,” Dr. Friedman said.

The study cites a 2003 survey  in which that 88% of dermatologists felt unprepared to respond to a biological attack.

“Encouragingly, though, 75% reported that disaster preparedness should be part of dermatology training, thus a formal training program is sorely needed to meet this demand,” the study notes.

Read Article Now

You May Also Like

Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
October 17, 2024

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…
Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
September 24, 2024

Dermatology Roundup: National Eczema Association Aims to Define “Flare”

By Allison Sit A National Eczema Association (NEA) study published in JAMA Dermatology identified patient-reported attributes associated with a “flare” of atopic dermatitis. The study sought to develop a clearer…
AcneAtopic DermatitisFeatured ArticlesJDD HighlightsJDD in the MediaPsoriasisSkin of ColorThe Latest
September 19, 2024

JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of Color

by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…

Leave a Reply